HOW DO PUBLIC HEALTH INSTITUTIONS DECIDE WHICH HEALTH TECHNOLOGIES ARE AVAILABLE IN MEXICO?

Published Nov 18, 2014
Mexico City, Mexico - Since improving the process for the submission of new health technologies in 2011, the Mexican Public Health Institution has also optimized public resources through the use of technologies (supplies) that have proven their safety, therapeutic efficacy, and efficiency. Researchers from the General Health Council describe the process of the submission of new health technologies in Public Health Institutions in México in the article, The Update of the Mexican Health Care Formulary and Supply Catalog in the Context of the Health Technology Assessment,” published in Value in Health Regional Issues.  One of the instruments that Mexico has available for the optimization of resources specifically allocated to health technologies is the Health Care Formulary and Supply Catalog (CBCISS). The importance of the CBCISS lies in the fact that all public institutions within the National Health System must use only the established technologies contained in the catalog. The implementation of strategies that strengthen the CBCISS update process ensures that each supply included on the list meets the sufficient and necessary criteria to ensure efficacy, safety, effectiveness, and, of course, efficiency, as evidence supporting the selection of suitable technologies. “It is necessary to promote the continuous improvement of the process of submission of new health technologies in Public Health Institutions in Mexico to ensure that each available supply represents the best option in terms of clinical effectiveness, cost-effectiveness and financial impact. Accordingly, decisions are being made based on the best available evidence in a context where the available resources are used efficiently, ensuring that the monetary resources expended will achieve the best health outcomes in the population”, says Dr. Pedro Rizo, MD, MHSM, Former Prioritization Deputy Director at General Health Council, Mexico and co-author of this article.

Related Stories

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Aug 7, 2023

Value in Health Regional Issues, the regionally focused journal of ISPOR, received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×